GlassScriptPhysician profile
Salam Zughayer
NPI 1205950045
$1,262.44
in general payments reported to CMS, 2019-2025
32 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,091 · 2022: $70.44 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $138.98 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $113.25 | 2019 | |
| Pfizer INC. | $101.31 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $92.80 | 2019 | |
| Genzyme Corporation | $89.51 | 2019 | |
| Biogen, INC. | $56.57 | 2019 | |
| Supernus Pharmaceuticals, INC. | $50.79 | 2019 | |
| Eisai INC. | $44.29 | 2019 | |
| Allergan, INC. | $42.78 | 2019 | |
| Genentech USA, INC. | $34.00 | 2019 | |
| Lilly USA, LLC | $32.84 | 2019 | |
| Greenwich Biosciences, INC. | $32.41 | 2019 | |
| Novartis Pharmaceuticals Corporation | $31.33 | 2019 | |
| Amgen INC. | $31.29 | 2019 | |
| Arbor Pharmaceuticals, INC. | $30.68 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $28.85 | 2019 | |
| Mallinckrodt Enterprises LLC | $28.49 | 2019 | |
| Lundbeck LLC | $28.23 | 2019 | |
| Amneal Pharmaceuticals LLC | $21.65 | 2019 | |
| Acadia Pharmaceuticals INC | $21.20 | 2019 | |
| Assertio Therapeutics, INC. | $20.82 | 2019 | |
| Avanir Pharmaceuticals, INC. | $20.42 | 2019 | |
| Upsher-Smith Laboratories LLC | $19.80 | 2019 | |
| Alexion Pharmaceuticals, INC. | $19.78 | 2019 | |
| Alnylam Pharmaceuticals INC. | $18.61 | 2019 | |
| Promius Pharma LLC | $17.95 | 2019 | |
| Ucb, INC. | $17.88 | 2019 | |
| Jazz Pharmaceuticals INC. | $17.61 | 2019 | |
| Emd Serono, INC. | $15.50 | 2019 | |
| Mdd US Operations, LLC | $15.32 | 2019 | |
| Adamas Pharmaceuticals, INC. | $14.56 | 2019 | |
| Medtronic USA, INC. | $12.94 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salam Zughayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.